X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3634) 3634
Publication (325) 325
Book Chapter (82) 82
Book Review (35) 35
Newsletter (29) 29
Newspaper Article (21) 21
Book / eBook (17) 17
Magazine Article (5) 5
Trade Publication Article (5) 5
Conference Proceeding (3) 3
Transcript (2) 2
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (2107) 2107
animals (1769) 1769
humans (1720) 1720
gastroenterology & hepatology (1191) 1191
rats (1167) 1167
female (1136) 1136
index medicus (1035) 1035
portal hypertension (877) 877
middle aged (855) 855
blood pressure - drug effects (717) 717
hypertension, portal - physiopathology (698) 698
cirrhosis (687) 687
adult (605) 605
hemodynamics - drug effects (592) 592
hypertension, portal - drug therapy (588) 588
liver cirrhosis (562) 562
hypertension (544) 544
liver (527) 527
rats, sprague-dawley (521) 521
portal-hypertension (509) 509
liver cirrhosis - complications (471) 471
aged (469) 469
liver cirrhosis - physiopathology (449) 449
liver circulation - drug effects (430) 430
portal vein (398) 398
hypertension, portal - etiology (347) 347
portal vein - drug effects (329) 329
hemodynamics (322) 322
pharmacology & pharmacy (308) 308
dogs (306) 306
liver - drug effects (302) 302
portal pressure - drug effects (296) 296
surgery (292) 292
treatment outcome (291) 291
hypertension, portal - complications (286) 286
vascular resistance - drug effects (278) 278
time factors (276) 276
pressure (274) 274
liver cirrhosis - drug therapy (265) 265
propranolol (265) 265
rats, wistar (260) 260
dose-response relationship, drug (251) 251
physiology (248) 248
liver - blood supply (244) 244
liver - metabolism (237) 237
portal vein - physiology (237) 237
splanchnic circulation - drug effects (229) 229
prevention (224) 224
heart rate - drug effects (218) 218
portal pressure (218) 218
gastroenterology and hepatology (217) 217
nitric-oxide (217) 217
hemorrhage (210) 210
in vitro techniques (209) 209
blood pressure (203) 203
liver diseases (201) 201
portal system - drug effects (200) 200
liver - pathology (198) 198
care and treatment (197) 197
nitric oxide (193) 193
risk factors (193) 193
blood-flow (189) 189
regional blood flow - drug effects (189) 189
research (188) 188
disease models, animal (187) 187
gastrointestinal hemorrhage - etiology (185) 185
rodents (181) 181
norepinephrine - pharmacology (170) 170
adrenergic beta-antagonists - therapeutic use (167) 167
transplantation (166) 166
fibrosis (163) 163
esophageal-varices (162) 162
venous pressure - drug effects (160) 160
rats, inbred strains (159) 159
ascites (156) 156
medicine (155) 155
ligation (154) 154
cirrhotic-patients (153) 153
esophageal and gastric varices - etiology (149) 149
portal vein - physiopathology (147) 147
propranolol - therapeutic use (147) 147
vasoconstriction - drug effects (144) 144
cardiac output - drug effects (143) 143
management (142) 142
perfusion (142) 142
research article (140) 140
esophageal and gastric varices - drug therapy (138) 138
liver cirrhosis, experimental - physiopathology (138) 138
medicine, general & internal (138) 138
medicine, research & experimental (138) 138
gastrointestinal hemorrhage - prevention & control (133) 133
mortality (132) 132
liver-cirrhosis (131) 131
nitric-oxide synthase (130) 130
health aspects (128) 128
drug therapy, combination (127) 127
liver transplantation (125) 125
vasoconstrictor agents - pharmacology (125) 125
antihypertensive agents - therapeutic use (124) 124
patients (124) 124
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Faculty of Information - Stacks (1) 1
OISE - Stacks (1) 1
Robarts - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3601) 3601
German (55) 55
Chinese (34) 34
Spanish (24) 24
French (21) 21
Japanese (18) 18
Russian (14) 14
Czech (9) 9
Korean (8) 8
Italian (5) 5
Arabic (2) 2
Polish (2) 2
Serbian (2) 2
Ukrainian (2) 2
Croatian (1) 1
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Scientific Reports, ISSN 2045-2322, 09/2016, Volume 6, Issue 1, pp. 33453 - 33453
Hepatic inflammation drives hepatic stellate cells (HSC), resulting in liver fibrosis. The Farnesoid-X receptor (FXR) antagonizes inflammation through NF-kappa... 
IN-VITRO | ACTIVATION | INHIBITION | MULTIDISCIPLINARY SCIENCES | LIVER FIBROSIS | STELLATE CELLS | FARNESOID-X RECEPTOR | FACTOR-KAPPA-B | NONALCOHOLIC STEATOHEPATITIS | GROWTH-FACTOR | PORTAL-HYPERTENSION | Inflammation - pathology | Kupffer Cells - pathology | Liver - pathology | Rats, Wistar | Apoptosis - drug effects | Humans | Hepatic Stellate Cells - metabolism | Male | NF-kappa B - metabolism | Hepatocytes - metabolism | Portal Pressure - drug effects | Inflammation - complications | Inflammation - drug therapy | Chenodeoxycholic Acid - therapeutic use | Inflammation Mediators - metabolism | Chenodeoxycholic Acid - pharmacology | Vascular Resistance - drug effects | Kupffer Cells - metabolism | Hepatic Stellate Cells - pathology | Hepatocytes - drug effects | Disease Models, Animal | Hepatic Stellate Cells - drug effects | Biomarkers - metabolism | Cell Line | Liver Cirrhosis - drug therapy | Cytokines - metabolism | Endothelial Cells - metabolism | Liver Cirrhosis - complications | Receptors, Cytoplasmic and Nuclear - agonists | Chenodeoxycholic Acid - analogs & derivatives | Kupffer Cells - drug effects | Up-Regulation - drug effects | Thioacetamide | Tumor Necrosis Factor-alpha - pharmacology | Animals | NF-KappaB Inhibitor alpha - metabolism | Lipopolysaccharides - pharmacology | Liver Cirrhosis - pathology | Cell Proliferation - drug effects | Hemodynamics - drug effects | Mice | Liver Cirrhosis - physiopathology | Cell Cycle - drug effects | Endothelial Cells - pathology | Endothelial Cells - drug effects | Inflammation - physiopathology | Receptors, Cytoplasmic and Nuclear - metabolism | Stellate cells | Platelet-derived growth factor | Cytokines | Liver X receptors | Kupffer cells | Connective tissue growth factor | Inflammation | Endothelial cells | Cirrhosis | Cell activation | Monocytes | Hepatocytes | Rodents | Fibrosis | Intoxication | Growth factors | Index Medicus
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2013, Volume 58, Issue 5, pp. 904 - 910
Background & Aims Resveratrol, a polyphenol found in a variety of fruits, exerts a wide range of beneficial effects on the endothelium, regulates multiple... 
Gastroenterology and Hepatology | Endothelial dysfunction | Oxidative stress | Thromboxane | Nitric oxide | CELLS | ACTIVATION | INCREASES | VASCULAR-TONE | LIVER | CCL4 | NITRIC-OXIDE | RESISTANCE | RED WINE | GASTROENTEROLOGY & HEPATOLOGY | Liver - pathology | Hypertension, Portal - physiopathology | Rats, Wistar | Stilbenes - therapeutic use | Endothelium, Vascular - drug effects | Male | Stilbenes - pharmacology | Liver Cirrhosis, Experimental - drug therapy | Liver Cirrhosis, Experimental - physiopathology | Hypertension, Portal - prevention & control | Dose-Response Relationship, Drug | Portal Pressure - drug effects | Liver - drug effects | Liver Cirrhosis - metabolism | Nitric Oxide Synthase Type III - metabolism | Disease Models, Animal | Liver Cirrhosis - prevention & control | Portal Pressure - physiology | Carbon Tetrachloride - adverse effects | Endothelium, Vascular - physiopathology | Rats | Antioxidants - pharmacology | Thromboxane A2 - metabolism | Antioxidants - therapeutic use | Liver - blood supply | Animals | Endothelium, Vascular - metabolism | Hypertension, Portal - metabolism | Liver Cirrhosis, Experimental - chemically induced | Liver Cirrhosis - physiopathology | Hypertension | COX-2 inhibitors | Carbon tetrachloride | Resveratrol | Fibrosis | Acetylcholine | Superoxide | Liver cirrhosis | Endothelium
Journal Article
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2007, Volume 5, Issue 8, pp. 932 - 937
Journal Article
Hepatology, ISSN 0270-9139, 07/2007, Volume 46, Issue 1, pp. 242 - 253
Journal Article
Hepatology, ISSN 0270-9139, 06/2017, Volume 65, Issue 6, pp. 2031 - 2044
Journal Article
Liver International, ISSN 1478-3223, 04/2015, Volume 35, Issue 4, pp. 1244 - 1252
Background & Aims In liver fibrosis, activated hepatic stellate cells (HSC) secrete excess extracellular matrix, thus, represent key targets for antifibrotic... 
HSC | liver fibrosis | TGF‐β1 | KCa3.1 | TRAM‐34 | TGF-β1 | Liver fibrosis | TRAM-34 | OPERATED CALCIUM-CHANNELS | KCa3 | ACTIVATED POTASSIUM CHANNELS | PROLIFERATION | 1 | RENAL FIBROSIS | SMOOTH-MUSCLE | TGF-1 | IN-VIVO | THROMBOXANE A | INTERMEDIATE-CONDUCTANCE | HYPERTENSION | GASTROENTEROLOGY & HEPATOLOGY | Liver - pathology | Intermediate-Conductance Calcium-Activated Potassium Channels - genetics | Transforming Growth Factor beta1 - metabolism | Actins - metabolism | Hepatic Stellate Cells - metabolism | Male | Intermediate-Conductance Calcium-Activated Potassium Channels - metabolism | Liver Cirrhosis, Experimental - drug therapy | Liver Cirrhosis, Experimental - physiopathology | Actins - genetics | Dose-Response Relationship, Drug | Portal Pressure - drug effects | Collagen Type I - genetics | Transfection | Liver - drug effects | Intermediate-Conductance Calcium-Activated Potassium Channels - antagonists & inhibitors | Liver Cirrhosis, Experimental - pathology | Vascular Resistance - drug effects | Hepatic Stellate Cells - pathology | Potassium Channel Blockers - pharmacology | Transforming Growth Factor beta1 - pharmacology | Hepatic Stellate Cells - drug effects | Pyrazoles - pharmacology | Cell Line | Collagen Type I - metabolism | Liver - metabolism | Gene Expression Regulation | Transforming Growth Factor beta1 - genetics | Liver Cirrhosis, Experimental - genetics | Rats, Sprague-Dawley | Animals | Signal Transduction - drug effects | Cell Proliferation - drug effects | Cell Cycle - drug effects | Liver Cirrhosis, Experimental - metabolism | Immunohistochemistry | Liver diseases | Collagen | Fibrosis | Bone morphogenetic proteins | Muscle proteins | Transforming growth factors | Gene expression
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 09/2017, Volume 313, Issue 3, pp. H676 - H686
Journal Article